EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Mouse mutants with neural tube closure defects and their role in understanding human neural tube defects



Mouse mutants with neural tube closure defects and their role in understanding human neural tube defects



Birth Defects Research. Part A, Clinical and Molecular Teratology 79(3): 187-210



BACKGROUND: The number of mouse mutants and strains with neural tube closure defects (NTDs) now exceeds 190, including 155 involving known genes, 33 with unidentified genes, and eight "multifactorial" strains. METHODS: The emerging patterns of mouse NTDs are considered in relation to the unknown genetics of the common human NTDs, anencephaly, and spina bifida aperta. RESULTS: Of the 150 mouse mutants that survive past midgestation, 20% have risk of either exencephaly and spina bifida aperta or both, parallel to the majority of human NTDs, whereas 70% have only exencephaly, 5% have only spina bifida, and 5% have craniorachischisis. The primary defect in most mouse NTDs is failure of neural fold elevation. Most null mutations (> 90%) produce syndromes of multiple affected structures with high penetrance in homozygotes, whereas the "multifactorial" strains and several null-mutant heterozygotes and mutants with partial gene function (hypomorphs) have low-penetrance nonsyndromic NTDs, like the majority of human NTDs. The normal functions of the mutated genes are diverse, with clusters in pathways of actin function, apoptosis, and chromatin methylation and structure. The female excess observed in human anencephaly is found in all mouse exencephaly mutants for which gender has been studied. Maternal agents, including folate, methionine, inositol, or alternative commercial diets, have specific preventative effects in eight mutants and strains. CONCLUSIONS: If the human homologs of the mouse NTD mutants contribute to risk of common human NTDs, it seems likely to be in multifactorial combinations of hypomorphs and low-penetrance heterozygotes, as exemplified by mouse digenic mutants and the oligogenic SELH/Bc strain.

(PDF emailed within 0-6 h: $19.90)

Accession: 013256857

Download citation: RISBibTeXText

PMID: 17177317

DOI: 10.1002/bdra.20333



Related references

An update to the list of mouse mutants with neural tube closure defects and advances toward a complete genetic perspective of neural tube closure. Birth Defects Research. Part A, Clinical and Molecular Teratology 88(8): 653-669, 2010

Maternal dietary uridine causes, and deoxyuridine prevents, neural tube closure defects in a mouse model of folate-responsive neural tube defects. American Journal of Clinical Nutrition 101(4): 860-869, 2015

Histological examination of neural tube closure in human embryos with reference to the early pathogenesis of neural tube defects. Teratology 22(1): 24A, 1980

Neural tube closure in humans initiates at multiple sites: Evidence from human embryos and implications for the pathogenesis of neural tube defects. Anatomy & Embryology 201(6): 455-466, June, 2000

Neural tube defects, chromosome abnormalities and multiple closure sites for the human neural tube. Clinical Dysmorphology 4(3): 202-207, 1995

Clinical teratology counseling and consultation case report: two distinct anterior neural tube defects in a human fetus: evidence for an intermittent pattern of neural tube closure. Teratology 48(5): 399-403, 1993

The absence of a relation between the periconceptional use of vitamins and neural-tube defects. National Institute of Child Health and Human Development Neural Tube Defects Study Group. New England Journal of Medicine 321(7): 430-435, 1989

Sex, neural tube defects, and multisite closure of the human neural tube. American Journal of Medical Genetics 58(4): 332-336, 1995

Neural tube defects: a review of human and animal studies on the etiology of neural tube defects. Teratology 34(2): 171-187, 1986

Neural tube defects at separate sites: further evidence in support of multi-site closure of the neural tube in humans. Surgical Neurology 71(3): 353-356, 2008

Nutri-epigenomic Studies Related to Neural Tube Defects: Does Folate Affect Neural Tube Closure Via Changes in DNA Methylation?. Mini Reviews in Medicinal Chemistry 15(13): 1095-1102, 2016

Triple neural tube defect and the multisite closure theory for neural tube defects: is there an additional site? Case report. Journal of Neurosurgery. Pediatrics 1(2): 160-163, 2008

Comment to the paper: Double neural tube defects: a case report and controversies around neural tube closure by Vashu Ravindran. Child's Nervous System 26(5): 705-705, 2010

Neural tube closure and neural tube defects: studies in animal models reveal known knowns and known unknowns. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics 135c(1): 59-68, 2005

Formate Supplementation May Prevent Some Neural Tube Defects that Prove Resistant to Folic Acid: Supplementation with formate rescued normal neural tube closure in more than three quarters of the embryos of novel folic acid-resistant neural tube defect mouse models. American Journal of Medical Genetics. Part A 176(8): 1697-1698, 2018